Fit and well (finding)
D0001 Swine Flu (Novel Influenza A H1N1) Vaccine Study
Year Started: 2009
Two new vaccines (Baxter swine flu & GSK swine flu vaccine) have been made against swine flu in response to the pandemic. These vaccines have been tested in adults, but there is less information on how well they work in children. This study will assess these two new vaccines in children aged between six months and twelve years
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Male
Infant (1 month - 2 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% | |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% | |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Child (6 - 12 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% | |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Infant (1 month - 2 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Child (6 - 12 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% | |
| Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0008 Multi-centre Study to Evaluate the Safety, Tolerability and Immunogenicity of Baxter H1N1 vaccine and GlaxoSmithKline H1N1 vaccine in children 6 months to 12 years of age
Year Started: 2009
D0008 Multi-centre Study to Evaluate the Safety, Tolerability and Immunogenicity of Baxter H1N1 vaccine and GlaxoSmithKline H1N1 vaccine in children 6 months to 12 years of age
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Child (6 - 12 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Female
Young child (2 - 6 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 11 - 25% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Child (6 - 12 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Male
Adolescent (12 - 18 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Adolescent (12 - 18 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Fit and well (finding)
D0009 Study to evaluate the induction of immune memory following infant vaccination with a glycol-conjugate Neisseria Meningitidis serogroup C Vaccine
Year Started: 2011
Please note, this collection consists of blood clots but it is listed as plasma. Study to evaluate the induction of immune memory following infant vaccination with a glycol-conjugate Neisseria Meningitidis serogroup C Vaccine and to assess the immune response to the concurrent infant routine immunisations administered in consistent versus alternating limbs.
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Child (6 - 12 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Female
Young child (2 - 6 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 11 - 25% |
Female
Adolescent (12 - 18 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Child (6 - 12 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Young child (2 - 6 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |
Male
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| DNA | -60°C to -85°C | N/A | Not applicable | 0 - 10% |